WallStSmart

Cushman & Wakefield plc (CWK)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 18% more annual revenue ($12.76B vs $10.82B). WELL leads profitability with a 12.1% profit margin vs 0.6%. CWK appears more attractively valued with a PEG of 0.25. WELL earns a higher WallStSmart Score of 57/100 (C).

CWK

Buy

55

out of 100

Grade: C

Growth: 4.0Profit: 4.5Value: 5.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.95

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CWKSignificantly Overvalued (-20.5%)

Margin of Safety

-20.5%

Fair Value

$11.59

Current Price

$12.90

$1.31 premium

UndervaluedFair: $11.59Overvalued
WELLSignificantly Overvalued (-87.0%)

Margin of Safety

-87.0%

Fair Value

$125.97

Current Price

$235.62

$109.65 premium

UndervaluedFair: $125.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CWK2 strengths · Avg: 10.0/10
PEG RatioValuation
0.2510/10

Growing faster than its price suggests

Price/BookValuation
1.5x10/10

Reasonable price relative to book value

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

CWK4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.954/10

Grey zone — moderate risk

Return on EquityProfitability
3.8%3/10

ROE of 3.8% — below average capital efficiency

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

Operating MarginProfitability
4.9%3/10

Operating margin of 4.9%

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CWK

The strongest argument for CWK centers on PEG Ratio, Price/Book. Revenue growth of 11.2% demonstrates continued momentum. PEG of 0.25 suggests the stock is reasonably priced for its growth.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : CWK

The primary concerns for CWK are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 45.4x leaves little room for execution misses. Thin 0.6% margins leave little buffer for downturns.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Key Dynamics to Monitor

CWK profiles as a value stock while WELL is a growth play — different risk/reward profiles.

CWK carries more volatility with a beta of 1.44 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 55/100) and 39.1% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cushman & Wakefield plc

REAL ESTATE · REAL ESTATE SERVICES · USA

Cushman & Wakefield plc, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom and internationally. The company is headquartered in Chicago, Illinois.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?